CIRANTAN

AstraZeneca (UK) Limited

Application Filed: 2000-04-17

Trademark Application Details

Mark For: CIRANTAN™ trademark registration is intended to cover the category of pharmaceutical preparations for use in the prevention and treatment of cardiovascular and circulatory diseases and disorders and diabetes. [all]

Status

2022-10-23 UTC

DEAD APPLICATION Refused Dismissed or Invalidated

This trademark application was refused, dismissed, or invalidated by the Office and this application is no longer active.

Research	OneLook Acronym Finder
Serial Number	76027123
Mark Literal Elements	CIRANTAN
Mark Drawing Type	1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S)
Mark Type	TRADEMARK
Standard Character Claim	No
Register	PRINCIPAL
Current Location	DIVISIONAL UNIT 2004-05-07
Basis	1(b)
Class Status	ACTIVE
Primary US Classes	006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	No
Current Use	No
Intent To Use	Yes
Filed ITU	Yes
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Domestic Representative	Graham Campaign PC
Attorney Name	H John Campaign
Law Office Assigned	L50
Employee Name	PIGNATELLO, ELIZABETH

Timeline

2000-04-17	Application Filed
2001-07-31	Published
2001-07-31	Published for Opposition
2004-05-07	Location: DIVISIONAL UNIT
2004-10-24	Abandon
2004-10-24	Status: Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all docume
2004-10-24	Status: Dead/Abandoned
2018-07-08	Transaction Date

Trademark Parties (Applicants & Owners)

Party:	AstraZeneca (UK) Limited
Address	15 Stanhope Gate London ENGLAND W1Y 6LN
Legal Entity Type	Limited Liability Company
Legal Entity State	UNITED KINGDOM

Documents

Application	IMAGE/TIFF	2000-04-17
Drawing	IMAGE/TIFF	2000-04-17
Duplicate Application		2000-04-17
Duplicate Drawing		2000-04-17
XSearch Search Summary		2000-09-19
Examiners Amendment		2000-09-21
Unclassified-Other		2000-09-25
Unclassified-Other		2001-06-10
Notice of Publication		2001-07-18
Notice of Allowance		2001-10-23
Extension of Time to File SOU		2002-04-03
Paper Correspondence Incoming		2002-04-03
Extension of Time to File SOU		2002-10-17
Paper Correspondence Incoming		2002-10-17
Extension of Time to File SOU		2003-04-23
Extension of Time to File SOU	APPLICATION/XML,IMAGE/TIFF	2003-04-23
Extension of Time to File SOU		2003-10-22
Extension of Time to File SOU		2003-10-22
ITU Extension Approval		2003-11-06
Extension of Time to File SOU		2004-04-23
Extension of Time to File SOU	APPLICATION/XML,IMAGE/TIFF	2004-04-23
File Jacket		2004-04-28
ITU Extension Approval		2004-05-05
Notice of Abandonment		2005-01-28

Attorney of Record

H JOHN CAMPAIGN
GRAHAM CAMPAIGN PC
36 WEST 44TH STREET, SUITE 1300
NEW YORK NY 10036-8178

Good, Services, and Codes

(ABANDONED)
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations for use in the prevention and treatment of cardiovascular and circulatory diseases and disorders and diabetes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	Pharmaceutical preparations for use in the prevention and treatment of cardiovascular and circulatory diseases and disorders and diabetes

Trademark Filing History

Description	Date	Proceeding Number
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED	2005-01-28
ABANDONMENT - NO USE STATEMENT FILED	2005-01-28	48494
SOU EXTENSION 5 GRANTED	2004-05-04
CASE FILE IN TICRS	2004-04-29
TEAS EXTENSION RECEIVED	2004-04-23
SOU EXTENSION 5 FILED	2004-04-23
SOU EXTENSION 4 GRANTED	2003-10-31
TEAS EXTENSION RECEIVED	2003-10-22
SOU EXTENSION 4 FILED	2003-10-22
SOU EXTENSION 3 GRANTED	2003-05-29
TEAS EXTENSION RECEIVED	2003-04-23
SOU EXTENSION 3 FILED	2003-04-23
SOU EXTENSION 2 GRANTED	2002-11-29
SOU EXTENSION 2 FILED	2002-10-17
PAPER RECEIVED	2002-10-17
SOU EXTENSION 1 GRANTED	2002-04-23
SOU EXTENSION 1 FILED	2002-04-03
PAPER RECEIVED	2002-04-03
NOA MAILED - SOU REQUIRED FROM APPLICANT	2001-10-23
PUBLISHED FOR OPPOSITION	2001-07-31
NOTICE OF PUBLICATION	2001-07-18
APPROVED FOR PUB - PRINCIPAL REGISTER	2000-09-27
EXAMINER'S AMENDMENT MAILED	2000-09-21
ASSIGNED TO EXAMINER	2000-09-18	77763

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
CIRANTAN 78505063 3113801 Dead/Cancelled	AstraZeneca UK Limited 2004-10-25
CIRANTAN 76027123 not registered Dead/Abandoned	AstraZeneca (UK) Limited 2000-04-17
CIRANTAN 74269312 1807005 Dead/Cancelled	IMPERIAL CHEMICAL INDUSTRIES PLC 1992-04-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.